Business Wire

GA-COCA-COLA

21.6.2022 15:43:06 CEST | Business Wire | Press release

Share
smartwater Announces Zendaya as Newest Global Brand Ambassador

smartwater is taking hydration to new heights this summer and today announces its newest global brand ambassador, Zendaya. A champion of artistry and originality, acclaimed actor and performer Zendaya is pioneering new ways to live a more purposeful life. As smartwater’s global ambassador, Zendaya will appear in a series of new creative from the brand that celebrates those who are defining ‘smart’ on their own terms and will support community water programs that will directly impact thousands of women.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005427/en/

“We could not be more thrilled to have Zendaya join smartwater as the newest face of our brand,” said Matrona Filippou, Global Category President, Hydration, Sports, Tea & Coffee, The Coca-Cola Company. “A global icon and cultural force, Zendaya isn’t afraid to be true to herself, and that’s what makes her the perfect addition to the smartwater family.”

Created in partnership with VMLY&R and WPP/OpenX, the campaign creative will begin rolling out in the U.S. from June 21 across television, audio, social and streaming channels, with global markets to follow. The campaign celebrates those who keep it smart, whatever the choice, and aren’t afraid to free themselves from the restraints of convention.

“I’m very excited to begin this new relationship with smartwater,” said Zendaya, smartwater Global Brand Ambassador. “We all know how important it is to stay hydrated and smartwater is my go-to source no matter what I am doing throughout the day.”

As the face of the brand’s newest campaign, Zendaya will work with smartwater to support community water quality and access improvements in various cities around the world, starting with Zendaya’s hometown of Oakland, California, by partnering with the Global Water Challenge (GWC) – a coalition of leading organizations collaborating to achieve universal access to clean drinking water. In the U.S. alone, 2.2 million people have no water at home and 44 million Americans are served by water systems that don't function optimally.

Together, smartwater, GWC and Zendaya are launching the smart solutions: global water challenge, which will invite local organizations to apply for grant funding to GWC’s women for water action platform that uplifts women and their communities through the power of clean water access. These efforts build on more than a decade of investments in clean water access around the world from The Coca-Cola Company which have reached more than 18.5 million people since 2010. GWC’s work has proven that with access to clean water, people, especially women and girls, are healthier, safer, educated and employed.

“Our organization doesn’t operate without the support of our purpose-driven partners, and we are grateful to have smartwater and Zendaya on board to help ensure communities in need have more access to clean water,” says Monica Ellis, CEO of Global Water Challenge. “With the smart solutions: global water challenge, we’ll specifically work to address community water access, improving and protecting water quality, and economic empowerment opportunities through water.”

For more information about smartwater, visit smartwater.com. For more information about the Global Water Challenge and the smart solutions: global water challenge, visit www.globalwaterchallenge.org .

About The Coca-Cola Company

The Coca-Cola Company (NYSE: KO) is a total beverage company with products sold in more than 200 countries and territories. Our company’s purpose is to refresh the world and make a difference. We sell multiple billion-dollar brands across several beverage categories worldwide. Our portfolio of sparkling soft drink brands includes Coca-Cola, Sprite and Fanta. Our hydration, sports, coffee and tea brands include Dasani, smartwater, vitaminwater, Topo Chico, BODYARMOR, Powerade, Costa, Georgia, Gold Peak and Ayataka. Our nutrition, juice, dairy and plant-based beverage brands include Minute Maid, Simply, innocent, Del Valle, fairlife and AdeS. We’re constantly transforming our portfolio, from reducing sugar in our drinks to bringing innovative new products to market. We seek to positively impact people’s lives, communities and the planet through water replenishment, packaging recycling, sustainable sourcing practices and carbon emissions reductions across our value chain. Together with our bottling partners, we employ more than 700,000 people, helping bring economic opportunity to local communities worldwide. Learn more at www.coca-colacompany.com and follow us on Twitter , Instagram , Facebook and LinkedIn .

About The Global Water Challenge

Global Water Challenge (GWC) is a coalition of leading organizations deploying expertise and networks to achieve universal access to safe and affordable drinking water, sanitation, and hygiene (WASH) in communities around the world. Since 2006, GWC has positively impacted more than 2 million people across Africa, the Americas and Asia with clean water access and its campaigns, tools, data and best practices reach millions more. In collaboration with multi-sector partners, GWC engages for action – catalyzing financial resources and driving innovative programming for sustainable, local solutions. GWC established the women for water platform to mobilize collective action for clean water access for every woman and her community. Currently scaling impact in 27 countries, women for water measurably contributes to economic empowerment outcomes while raising awareness for this important issue. For more information, please visit globalwaterchallenge.org .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye